Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for MEN1-associated primary hyperparathyroidism
2008-005055-23Phase 4Active
- Sponsor
- Policlinico di Milano
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cinacalcet in primary hyperparathyroidism (PHPT) and Multiple endocrine neoplasia type 1 (MEN1), sponsored by Policlinico di Milano. Primary endpoint: Efficacy and safety of cinacalcet in primary hyperparathyroidism in MEN1. Started Mar 2010; status: active.
02
Drugs
cinacalcet
03
Conditions
primary hyperparathyroidism (PHPT)Multiple endocrine neoplasia type 1 (MEN1)
Beyond the preview
Go deeper on 2008-005055-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005055-23.